Gnosis Health is a digital health and artificial intelligence company focused on transforming the management of chronic disease through personalised, clinically informed AI systems. Its flagship platform, MAXine, leverages adaptive models, real-time patient data, and evidence-based frameworks to deliver tailored guidance, symptom tracking, and decision support for patients and clinicians. Co-founded by Professor Edward Meinert and Jerrell Schivers, Gnosis Health brings together deep clinical research and advanced engineering to build scalable, patient-centric healthcare solutions.
Gnosis Health
- Health
- Newcastle, United Kingdom
- £1.1m
- gnosisealth.ai
- Update Information
More venture news
- 16 Jul 2026

BeCertainBeCertain raises a £1.7m pre-seed round led by Sure Valley Ventures for AI software that helps dentists interpret X-rays
Pre-seedHealth - 9 Jul 2026

Leo Cancer CareLeo Cancer Care unlock £50m Series D led by Yu Galaxy for its upright imaging and radiotherapy platform
Series DHealth - 8 Jul 2026

Respiro DiagnosticsRespiro Diagnostics raises a £1m pre-seed round led by Zinc Venture Capital and SFC Capital to develop breath-based liquid biopsy for lung cancer
Pre-seedHealth
